Cancer stem cells and telomerase as potential biomarkers in veterinary oncology

Research output: Contribution to journalLiterature reviewpeer-review

Abstract

Despite advances in chemotherapy and radiotherapy, cancer remains a disease of high morbidity and mortality in domestic animals. In parallel to the development of novel therapeutic interventions, appropriate biomarkers are required to detect early-stage disease and disease remission and relapse at both gross and molecular levels, and the effectiveness of therapy. The field of cancer pathogenesis has grown exponentially over the last decade, both in terms of our understanding of the underlying molecular events, and the technologies available to interrogate the cancer cell. This paper reviews the role of the telomerase enzyme and of telomere length as potential biomarkers in cancer. Furthermore, the potential role of cancer stem cells as biomarkers of malignancy and disease progression is assessed. (C) 2010 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalVeterinary Journal
Volume185
Issue number1
DOIs
Publication statusPublished - Jul 2010

Keywords

  • Cancer
  • Stem cells
  • Telomerase
  • Biomarkers
  • Veterinary oncology
  • ACUTE MYELOID-LEUKEMIA
  • LUNG-CANCER
  • DISEASE EVOLUTION
  • PROGENITOR CELLS
  • PROSTATE-CANCER
  • IDENTIFICATION
  • MARKER
  • GENE
  • EXPRESSION
  • TUMORS

Cite this